跳至主要内容
临床试验/NL-OMON45498
NL-OMON45498已完成不适用

Effect of the number of epoetin alpha injections on the hemoglobin level of anaemic patients eligible for elective orthopedic surgery - Effect of EPO on Hb level of anaemic patients

Sint Maartenskliniek0 个研究点目标入组 45 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 64(—)

入选标准

  • Indication for treatment with epoetin alpha according to current guidelines and the opinion of the anaesthesiologists. Epoetin alpha is prescribed to patients with a preoperative Hb level between 10.0 * 13.0 g/dL, scheduled for elective orthopedic surgery with an expected blood loss of 900-1800 mL.

排除标准

  • * Any contra-indication for the use of epoetin alpha (hypersensitivity to epoetin alpha or any component of the formulation, uncontrolled hypertension, pure red cell aplasia due to epoetin alpha)
  • * Myocardial infarction or cerebral vascular accident within 6 months before inclusion
  • * Serious coronary disease
  • * Sickle cell anemia
  • * Pregnancy or lactation
  • * Existing use of iron supplementation

研究者

相似试验